The opinion
PRECEDENTIAL
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
______
Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602
& 14-4632
______
IN RE: LIPITOR ANTITRUST LITIGATION
Rite Aid Corporation; Rite Aid Hdqtrs. Corporation; JC (PJC)
USA, LLC; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd
Corporation,
Appellants in No. 14-4202
Walgreen Company; The Kroger Co.; Safeway, Inc.;
Supervalu, Inc.; HEB Grocery Company L.P.,
Appellants in No. 14-4203
Giant Eagle, Inc.,
Appellant in No. 14-4204
Meijer, Inc.; Meijer Distribution, Inc.,
Appellants in No. 14-4205
Rochester Drug Co-Operative, Inc.; Stephen L. LaFrance
Pharmacy, Inc. d/b/a SAJ Distributors; Burlington Drug
Company, Inc.; Value Drug Company; Professional Drug
Company, Inc.; American Sales Company LLC,
Appellants in No. 14-4206
A.F.L.-A.G.C. Building Trades Welfare Plan; Mayor and City
Council of Baltimore, Maryland; New Mexico United Food
and Commercial Workers Union’s and Employers’ Health
and Welfare Trust Fund; Louisiana Health Service Indemnity
Company, d/b/a Blue Cross/Blue Shield of Louisiana; Bakers
Local 433 Health Fund; Twin Cities Bakery Workers Health
and Welfare Fund; Fraternal Order of Police, Fort Lauderdale
Lodge 31, Insurance Trust Fund; International Brotherhood of
Electrical Workers Local 98; New York Hotel Trades
Counsel & Hotel Association of New York City, Inc., Health
Benefits Fund; Edward Czarnecki; Emilie Heinle; Frank
Palter; Andrew Livezey; Edward Ellenson; Jean Ellyne
Dougan; Nancy Billington, on behalf of themselves and all
others similarly situated,
Appellants in No. 14-4602
RP Healthcare, Inc.; Chimes Pharmacy, Inc.; James
Clayworth, R.Ph., d/b/a Clayworth Pharmacy; Marin
Apothecaries, Inc., d/b/a Ross Valley Pharmacy; Golden Gate
Pharmacy Services, Inc., d/b/a Golden Gate Pharmacy;
Pediatric Care Pharmacy, Inc.; Meyers Pharmacy, Inc.; Tony
Mavrantonis R. Ph., d/b/a Jack’s Drugs; Tilley Apothecaries
Inc., d/b/a Zweber’s Apothecary,
Appellants in No. 14-4632
2
______
Nos. 15-1184, 15-1185, 15-1186, 15-1187, 15-1274, 15-1323
& 15-1342
______
IN RE: EFFEXOR XR ANTITRUST LITIGATION
Walgreen, Co.; The Kroger, Co.; Safeway, Inc.; Supervalu,
Inc.; HEB Grocery Company LP; American Sales Company,
Inc.,
Appellants in No. 15-1184
Rite Aid Corporation; Rite Aid Hdqtrs., Corporation; JCG
(PJC) USA, LLC; Maxi Drug, Inc. d/b/a Brooks Pharmacy;
Eckerd Corporation; CVS Caremark Corporation,
Appellants in No. 15-1185
Giant Eagle, Inc.,
Appellant in No. 15-1186
Meijer, Inc.; Meijer Distribution, Inc.,
Appellants in No. 15-1187
Professional Drug Company, Inc.; Rochester Drug Co-
Operative, Inc.; Stephen L. LaFrance Holdings, Inc.; Stephen
L. LaFrance Pharmacy, Inc. d/b/a SAJ Distributors;
Uniondale Chemist, Inc.,
Appellants in No. 15-1274
3
Painters District Council No. 30 Health & Welfare Fund;
Medical Mutual of Ohio,
Appellants in No. 15-1323
A.F.L.-A.G.C. Building Trades Welfare Plan; Daryl Deino;
IBEW-NECA Local 505 Health & Welfare Plan; Louisiana
Health Service Indemnity Company d/b/a Blue Cross/Blue
Shield of Louisiana; Man-U Service Contract Trust Fund;
MC-UA Local 119 Health & Welfare Plan; New Mexico
United Food and Commercial Workers Union’s and
Employers’ Health and Welfare Trust Fund; Plumbers and
Pipefitters Local 572 Health and Welfare Fund; Sergeants
Benevolent Association Health and Welfare Fund; Patricia
Sutter (together “End-Payor Class Plaintiffs”) on behalf of
themselves and all others similarly situated,
Appellants in No. 15-1342
______
On Appeal from the United States District Court
for the District of New Jersey
(MDL 2332) / (D.N.J. No. 3-12-cv-02389) / (D.N.J. No. 3-
12-cv-02478) / (D.N.J. No. 3-12-cv-02519) / (D.N.J. No. 3-
12-cv-04115) / (D.N.J. No. 3-12-cv-04537) / (D.N.J. No. 3-
12-cv-05129) / (D.N.J. No. 3-12-cv-06774) / (D.N.J. No. 3-
12-cv-07561)
(D.N.J. No. 3-11-cv-05479) / (D.N.J. No. 3-11-cv-05590) /
(D.N.J. No. 3-11-cv-05661) / (D.N.J. No. 3-11-cv-06985) /
(D.N.J. No. 3-11-cv-07504) / (D.N.J. No. 3-12-cv-03116) /
(D.N.J. No. 3-12-cv-03523)
______
ORDER AMENDING OPINION
4
______
At the direction of the Court, the opinion filed on April
13, 2017 is amended as follows:
Page 21, first full paragraph, third line: <four individual-
retailers asserting direct-purchaser claims> is changed to
<several individual-retailers asserting direct-purchaser
claims>.
Page 21, first full paragraph, ninth line: delete <several>
before <California-based pharmacists>.
Page 25, only full paragraph, second line: <'983 Patent> is
changed to <'893 Patent>.
Page 28, fourth paragraph, fourth line: <four individual-
retailers asserting direct-purchaser claims> is changed to
<several individual-retailers asserting direct-purchaser
claims>.
Page 31, second paragraph, fourth line: <four individual-
retailers filed complaints> is changed to <several individual-
retailers filed complaints>.
Page 43, first full paragraph, first line: <Our jurisdictional
holding is consistent, we think, with two of the Second
Circuit’s pre-Actavis reverse-payment cases.> is changed to
<Our jurisdictional holding is consistent, we think, with two
of the Second Circuit’s pre-Actavis cases.>.
5
Page 43, first full paragraph, tenth line: <(per curiam)> is
added after <Arkansas Carpenters Health & Welfare v. Bayer
AG, 604 F.3d 98, 103 n.10 (2d Cir. 2010)>.
Page 44, first full paragraph, first line: <And in DDAVP, 585
F.3d 677, the Second Circuit retained jurisdiction over a
reverse-payment case.> is changed to <And in DDAVP, 585
F.3d 677, the Second Circuit retained jurisdiction over an
antitrust case presenting patent-law issues.>.
For the Court,
Marcia M. Waldron, Clerk
Date: April 19, 2017
mlr/cc: all counsel
6